Apr 27, 2020

Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer.  Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like...

Apr 27, 2020

Maurice Zauderer, CEO, Vaccinex discusses pepinemab, the antibody drug being developed by Vaccinex for treatment of Huntington's disease, Alzheimer's disease and lung cancer.  Maurice also touches on the relationship between neurodegenerative diseases and cancer, and the commonalities that allow for a treatment like...

Apr 13, 2020

Dr. William Frey, Senior Research Director, Center for Memory and Aging, HealthPartners Neuroscience Center shares his insights about delivering therapeutic agents to the brain by-passing the blood-brain barrier.  Based on an unusual dream he had in 1989, Bill has been on the path to discover and patent a noninvasive...

Apr 13, 2020

Dr. William Frey, Senior Research Director, Center for Memory and Aging, HealthPartners Neuroscience Center shares his insights about delivering therapeutic agents to the brain by-passing the blood-brain barrier.  Based on an unusual dream he had in 1989, Bill has been on the path to discover and patent a noninvasive...

Feb 17, 2020

Brad Margus, CEO, Cerevance talks about discovering and developing novel therapies for central nervous system diseases using the Cerevance powerful NETSseq target discovery platform and their large collection of human brain tissue samples.  Brad explains why the brain is such a challenging organ to study and their...